Estar Technologies Ltd. of Holon at MEDICA 2018 in Düsseldorf -- COMPAMED Trade Fair

Estar Technologies Ltd.

P.O. Box 2150, 58121 Holon
15 Hamerkava Street, 5885111 Holon
Telephone +972 3 5596414
Fax +972 3 5596424

This company is co-exhibitor of
Israel Export & International Cooperation Institute

Hall map

MEDICA 2018 hall map (Hall 16): stand G40

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 05  Commodities and Consumer Goods
  • 05.15  Wound care equipment
  • 05.15.07  Wound covering / skin substitutes

Wound covering / skin substitutes

Our products

Product category: Wound covering / skin substitutes

Tropocells® system

Tropocells® system is a proprietary platform based on blood separation according to density using a unique separation gel. The system allows for the preparation of pure PRP with optimal platelet concentrations and cellular content. Virtually, all Red Blood Cells (RBC) are eliminated from PRP and the concentration of pro-inflammatory Granulocytes (GRs) is dramatically reduced.

PRP is prepared by taking a small sample of the patient’s own blood, then separating platelets from Platelet-Poor Plasma (PPP), RBC and GRs via centrifugation. PRP is then collected and can be applied the treated site to promote soft and hard tissue regeneration. The whole preparation process takes up to 20 minutes.

  •  A progressive non-surgical healing treatment in a variety of fields, including dermal aesthetics, sports medicine, orthopedics, dentistry, wound healing etc.
  •  A fraction of autologous blood with supraphysiological concentration of platelets and their associated growth factors.
  • Upon activation, platelet-derived α granules release autologous growth factors involved in cell proliferation, angiogenesis, collagenesis and matrix remodelling (PDGF/ TGF/ VEGF/ EGF/ FGF/ IGF etc).
  • PRP is thought to promote physiological  wound healing and rapid tissue regeneration
  • Autologous (from patient’s own blood)
  • Easy to use, rapid and effective system
  • Requires small sample of blood (10-60ml)
  •  Optimal Platelet Concentration
  • Biocompatible, and xeno-free, minimizing safety concerns and rejection
  •  Control of  PRP volume by discarding PPP
  • Increases platelet concentration
  • Adjustment to clinical protocols
  • Specially designed accessories to facilitate PRP harvest
  • Virtually eliminating granulocytes from the PRP, which are considered not beneficial in terms of regeneration process and may contribute to a catabolic effect by secreting catabolic mediators, including metalloproteinases.
  • Eliminating undesired erythrocytes, which have been shown to significantly decrease fibroblast proliferation and augment apoptosis in vitro.
  • Remnant of mononuclear cells present in the PRP assists in fighting infection and is thought to enhance the anabolic effects of PRP.

• Enables high platelet concentration of X4-5 fold compared to baseline

• Rapid and simple process – only one centrifugation

• Adjustment to a specific clinical application by controlling the final PRP volume

• Compatible with OR and/or doctor’s office setting

More Less

About us

Company details

Estar Medical was founded in 1992 by Aaron Esteron - a polymer-science expert, entrepreneur and prolific inventor. Aaron, a pioneer in the development of vacuum collection and separation systems for blood and urine, was one of the first in the world to commercialize this line of products, which is currently being manufactured both in Israel and abroad.

From 2008, Estar Medical has taken a huge technological leap forward by investing in the creation and development of its own state of the art proprietary technologies and systems for the Regenerative Medicine arena. The flagship product of Estar’s in-house development is the "Tropocells®" Platelet Preparation System for the separation of platelet concentrate (PRP) from the patient's own blood.

Estar Medical produces, manufactures and distributes the Tropocells® PRP System and the Cellenis® PRP System in more than 50 countries worldwide. Estar Medical prides itself of being totally committed to the innovation and quality of its unique technology as well as for creating the next generation of its proprietary Tropocells® medical platform.

More Less